The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

The University of Birmingham’s Cancer Research UK Clinical Trials Unit is leading a new trial to improve outcomes for ...

The method employs ultrathin membranes to capture small packets of cellular material known as extracellular vesicles. Cells ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each ...

Ichnos Glenmark Innovation's cancer drug ISB 2001 shows promising results in Phase 1 trial, to be presented at ASH.

CRUK has invested more than £43 million into the RadNet programme since it was launched in 2019, and Manchester is one of ...

In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right ...

Could the controversial COVID drug hydroxychloroquine be repurposed as a promising medication for cancer? Researchers believe ...

Treatment for rectal cancer may differ from that of colon cancer because of the increased risk of recurrence and poorer ...

Scientists and clinicians at the University of Leeds exploring new radiotherapy treatments and technologies have been given a ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced the appointment of Claudia Lopez, DVM, MSc, as its new Vice President, Clinical Product Development. Dr. Lopez ...